| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |